Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 4, 2006, Pages 679-689

  Mitra, Aparna ^a   Chakrabarti, Jayati ^a   Banerji, Aniruddha ^a   Chatterjee, Amitava ^a   Das, B R ^b  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b Research and Development Division   (India)

Author keywords

Curcumin; FAK; Integrin; Invasion; MMP 2

Indexed keywords

CURCUMIN; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE INHIBITOR; INTEGRIN RECEPTOR; INTERSTITIAL COLLAGENASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL ASSAY; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LARYNX CARCINOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 34047240829     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i4.70     Document Type: Article

References (32)

1. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer. 2002;98:234-40.
2. Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44:97-111.
3. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/ progression stages of colon cancer. Cancer Res. 1999;59:597-601.
4. Mehta K, Pintails P, McQueen T, Aggarwal BB. Antiproliferative effect of curcumin (difeuroyl methane) against human breast tumour cell lines. Anticancer Drugs. 1997;8:470-81.
5. Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH, Min do S, Chang JS, Jeong YJ, Lee YH, Park JW, Kwon TK. Molecular mechanisms of curcumin induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, downregulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 2003;24:1199-208.
6. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary cucumin on fore-stomach, duodenal and colon carcinogenesis in mice. Cancer Res. 1994;54:5841-7.
7. Leu TH, Maa MC. The molecular mechanisms for the anti-tumorigenic effect of curcumin. Curr Med Chem Anti-Cancer Agents. 2002;2:357-70.
8. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH. Co-operative signaling by α5β1and α4β1 integrin regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol. 1995;129:867-79.
9. Vihinen P, Kahari VM. Matrixmetalloproteinases in Cancer: Prognostic markers and therapeutic targets. Int J Cancer. 2002;99:157-66.
10. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72kDa type IV collagenase. J Biol Chem. 1995;270:5331-8.
11. Kurschat P, Zigrino P, Nischt R, Breitkopf K, Steurer P, Klein CE, Krieg T, Mauch C. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane -type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem.1999;274:21056-62.
12. Egebald M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161-74.
13. Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, Chou HY, Chien CT, Chen WJ, Lee YT, Yang PC. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on high throughput microarray analysis. Mol Pharmacol. 2004; 65:99-110.
14. Nakahara H, Howard L, Thompson EW. Transmembrane/cytoplasmic domain-mediated membrane type1 matrixmetalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA. 1997;94:7959-64.
15. Huang TS, Lee SC, Lin JK. Suppression of c-Jun/Ap-1 activation by an inhibitor of tumour promotion in mouse fibroblast cells. Proc Natl Acad Sci USA. 1991;88:5292-6.
16. Banerji A, Chakrabarti J, Mitra A, Chatterjee A. Effect of curcumin on Gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett. 2004; 211: 235-42.
17. Ray S, Chattopadhyay N, Mitra A, Siddiqi M, Chatterjee A. Curcumin exhibits anti-metastatic properties by modulating integrin receptors, collagenase activity and expression of nm23 and e-cadherin in a highly metastasising B16F10 melanoma cell line. J Environ Pathol Toxicol Oncol. 2003;22:49-58.
18. Kim HY, Park EJ, Joe EH, Jou I. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol. 2003;171:6072-9.
19. Wong H, Muzik H, Groft LL, Lafleur MA, Matouk C, Forsyth PA, Schultz GA, Wall SJ, Edwards DR. Monitoring MMP and TIMP mRNA expression by RT-PCR. In: Clark IM, editor. Matrix metalloproteinase protocols. Totowa, NJ: Humana Press.; 2001.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
21. Unemori EN, Werb Z. Reorganization of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol. 1986;103:1021-31.
22. Hofmann UB, Westphal JR, Waas ET, Becker JC, Ruiter DJ, van Muijen GN. Coexpression of integrin αvβ3 and matrix metalloproteinase 2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. J Invest Dermatol. 2000;115:625-32.
23. Kubota S, Itoh H, Ishibasi Y, Seyama Y. Antialpha3 integrin antibody induces the activated form of matrix metalloprotease-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells. Int J Cancer. 1997;70:106-11.
24. Mitra A, Chakrabarti J, Chatterjee A. Binding of α5 monoclonal antibody to cell surface α5β1 integrin modulates MMP-2 & MMP-7 activity in B16F10 melanoma cells. J Environ Pathol Toxicol Oncol. 2003;22:167-78.
25. Mitra A, Chakrabarti J, Banerji A, Chatterjee A. Binding of α2 monoclonal antibody to human cervical tumor cell (SiHa) surface α2β1 integrin modulates MMP-2 activity. Gynecol Oncol 2004;94:33-39.
26. Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 2005;280:9409-15.
27. Fenton JI, Wolff MS, Orth MW, Hord NG. Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype. Carcinogenesis. 2002;23:1065-70.
28. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-32.
29. Schlaepfer DD, Hunter T. Evidence for in vivo phosphorylation of the GRB2 SH2 domain binding site on focal adhesion kinase by Src-family protein tyrosine kinases. Mol Cell Biol. 1996;16:5623-33.
30. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, Liu ET, Cance WG. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumours. Cancer Res. 1995;55:2752-5.
31. Agochiya M, Brunton VG, Owens DW, Parkinson EK, Paraskeva C, Keith WN, Frame MC. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene. 1999;18:5646-53.
32. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2000;2:249-56.